Chemoinformaics analysis of delphinidin 3-O-beta-D-glucoside-5-O-beta-D-glucoside betaine
Molecular Weight | 626.52 | nRot | 7 |
Heavy Atom Molecular Weight | 596.28 | nRig | 2 |
Exact Molecular Weight | 626.148 | nRing | 5 |
Solubility: LogS | -0.541 | nHRing | 3 |
Solubility: LogP | 0.808 | No. of Aliphatic Rings | 4 |
Acid Count | 0 | No. of Aromatic Rings | 1 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
Atoms Count | 74 | No. of Aliphatic Hetero Cycles | 3 |
No. of Heavy Atom | 44 | No. of Aromatic Carbocycles | 1 |
nHetero | 17 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 30 | No. of Saturated Hetero Cycles | 2 |
No. of Carbon atom | 27 | No. of Saturated Rings | 2 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
No. of Oxygen atom | 17 | No. of Arom Bond | 16 |
nHA | 17 | APOL | 78.7278 |
nHD | 11 | BPOL | 39.6442 |
QED | 0.459 |
Synth | 2.942 |
Natural Product Likeliness | 1.13 |
NR-PPAR-gamma | 0.16 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0.001 |
Pgp-sub | 0.002 |
HIA | 0.004 |
CACO-2 | -4.27 |
MDCK | 0.0000413 |
BBB | 0.993 |
PPB | 0.528408 |
VDSS | 0.986 |
FU | 0.592479 |
CYP1A2-inh | 0.181 |
CYP1A2-sub | 0.448 |
CYP2c19-inh | 0.042 |
CYP2c19-sub | 0.766 |
CYP2c9-inh | 0.011 |
CYP2c9-sub | 0.287 |
CYP2d6-inh | 0.004 |
CYP2d6-sub | 0.417 |
CYP3a4-inh | 0.01 |
CYP3a4-sub | 0.252 |
CL | 8.785 |
T12 | 0.842 |
hERG | 0.01 |
Ames | 0.849 |
ROA | 0.948 |
SkinSen | 0.874 |
Carcinogencity | 0.905 |
EI | 0.989 |
Respiratory | 0.972 |
NR-Aromatase | 0.021 |
Antiviral | Yes |
Prediction | 0.807622 |